MetaADEDB 2.0 @ LMMD
urapidil
(ICMGLRUYEQNHPF-UHFFFAOYSA-N)
Structure
SMILES
COc1ccccc1N1CCN(CC1)CCCNc1cc(=O)n(c(=O)n1C)C
Type(s)
Investigational
ATC code(s)
C02CA06
Molecular Formula:
C20H29N5O3
Molecular Weight:
387.476
Log P:
0.7927
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
1
TPSA:
71.74
CAS Number(s):
34661-75-1; 64887-14-5
Synonym(s)
1.
urapidil
2.
6-(3-(4-(o-methoxyphenyl)-1-piperazinyl)propylamino)-1,3-dimethyluracil
3.
Ebrantil
4.
urapidil monohydrochloride
5.
urapidil, 2,3-(14)C2-labeled
6.
urapidil, 5-(14)C-labeled
External Link(s)
MeSHC015568
PubChem Compound5639
BindingDB50237617
ChEBI32278
CHEMBLCHEMBL279229
DrugBankDB12661
DrugCentral2796
KEGGdr:D01333
Therapeutic Target DatabaseD0K0VO
D0M8BE
ZINC1544805
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AcidosisOFFSIDES
2Acute Coronary SyndromeOFFSIDES
3Acute prerenal failureOFFSIDES
4AdenomaOFFSIDES
5AgraphiaOFFSIDES
6AkinesiaOFFSIDES
7Alcoholic IntoxicationOFFSIDES
8Altered state of consciousnessOFFSIDES
9Anal abscessOFFSIDES
10AnalgesiaOFFSIDES
11Anastomotic stenosisOFFSIDES
12AngioedemaOFFSIDES
13Anti-thyroid antibody positiveOFFSIDES
14Antipsychotic drug level increasedOFFSIDES
15AnuriaOFFSIDES
16ApathyOFFSIDES
17Arteriosclerosis ObliteransOFFSIDES
18ArteritisOFFSIDES
19Aspiration PneumoniaOFFSIDES
20Basophil count abnormalOFFSIDES
21Blood albumin decreasedOFFSIDES
22Blood aldosterone increasedOFFSIDES
23Blood amylase increasedOFFSIDES
24Blood antidiuretic hormone decreasedOFFSIDES
25Blood chloride decreasedOFFSIDES
26Blood cholinesterase decreasedOFFSIDES
27Blood creatinine increasedOFFSIDES
28Blood iron decreasedOFFSIDES
29Blood osmolarity increasedOFFSIDES
30Blood pressure inadequately controlledOFFSIDES
31Blood sodium increasedOFFSIDES
32Blood sodiumOFFSIDES
33Blood triglyceridesOFFSIDES
34Blood urea increasedOFFSIDES
35Blood uric acid decreasedOFFSIDES
36BradycardiaOFFSIDES
37Brain DeathOFFSIDES
38Bronchial ObstructionOFFSIDES
39Cardioactive drug level increasedOFFSIDES
40Cardiovascular insufficiencyOFFSIDES
41Catheter site painOFFSIDES
42Catheter site swellingOFFSIDES
43ChorioamnionitisOFFSIDES
44Chronic left ventricular failureOFFSIDES
45CraniotomyOFFSIDES
46Creatinine renal clearance decreasedOFFSIDES
47Cytolytic hepatitisOFFSIDES
48Cytomegalovirus test positiveOFFSIDES
49DehydrationOFFSIDES
50Depressed Level of ConsciousnessOFFSIDES
51Device related infectionOFFSIDES
52Diabetic NephropathyOFFSIDES
53Disease recurrenceOFFSIDES
54Dyspnea3230472CTD
55Electrocardiogram repolarisation abnormalityOFFSIDES
56EpilepsyOFFSIDES
57Escherichia urinary tract infectionOFFSIDES
58Essential HypertensionOFFSIDES
59False positive laboratory resultOFFSIDES
60Fluid overloadOFFSIDES
61Gamma-Glutamyltransferase IncreasedOFFSIDES
62Gastroenteritis norovirusOFFSIDES
63General physical conditionOFFSIDES
64General physical health deteriorationOFFSIDES
65Glasgow coma scaleOFFSIDES
66GlobulinuriaOFFSIDES
67GlomerulonephritisOFFSIDES
68Granulocyte count increasedOFFSIDES
69Heparin-induced thrombocytopeniaOFFSIDES
70Hepatitis COFFSIDES
71Hypotension3023106CTD
72HypoxiaOFFSIDES
73Karnofsky scale worsenedOFFSIDES
74Kidney FailureOFFSIDES
75Large intestine perforationOFFSIDES
76LipaseOFFSIDES
77LymphoceleOFFSIDES
78Lymphocyte count decreasedOFFSIDES
79Lymphocyte percentage decreasedOFFSIDES
80Lymphocyte stimulation test positiveOFFSIDES
81Malignant HypertensionOFFSIDES
82Malignant ascitesOFFSIDES
83MarasmusOFFSIDES
84Mechanical ventilationOFFSIDES
85Mental impairmentOFFSIDES
86Muscle tightnessOFFSIDES
87NephroangiosclerosisOFFSIDES
88Neuroleptic Malignant SyndromeOFFSIDES
89OverdoseOFFSIDES
90Percutaneous Coronary InterventionOFFSIDES
91PericarditisOFFSIDES
92PeritonitisOFFSIDES
93PhlebitisOFFSIDES
94Pneumococcal sepsisOFFSIDES
95Pneumocystis jiroveci pneumoniaOFFSIDES
96Postoperative Complications9829161CTD
97Pre-Eclampsia9829161CTD
98Procedural site reactionOFFSIDES
99Protein total decreasedOFFSIDES
100Prothrombin level decreasedOFFSIDES
101Prothrombin time abnormalOFFSIDES
102Prothrombin time ratio decreasedOFFSIDES
103PsoriasisOFFSIDES
104PyonephrosisOFFSIDES
105Renal ColicOFFSIDES
106Renal dysplasiaOFFSIDES
107Renal tubular disorderOFFSIDES
108Renin increasedOFFSIDES
109RhabdomyolysisOFFSIDES
110Rheumatoid NoduleOFFSIDES
111SarcoidosisOFFSIDES
112SclerodermaOFFSIDES
113Sclerosing encapsulating peritonitisOFFSIDES
114SeromaOFFSIDES
115Sick Sinus SyndromeOFFSIDES
116Sinus bradycardiaOFFSIDES
117Superficial ThrombophlebitisOFFSIDES
118Suture ruptureOFFSIDES
119Tachycardia3007177CTD
120TalipesOFFSIDES
121ThrombophlebitisOFFSIDES
122Ureteral necrosisOFFSIDES
123Ureteral stent insertionOFFSIDES
124Urine output increasedOFFSIDES
125Wound dehiscenceOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.